Waverton Investment Management Ltd Acquires 316 Shares of Danaher Corporation $DHR

Waverton Investment Management Ltd grew its holdings in Danaher Corporation (NYSE:DHR) by 12.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,770 shares of the conglomerate’s stock after purchasing an additional 316 shares during the quarter. Waverton Investment Management Ltd’s holdings in Danaher were worth $547,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Resona Asset Management Co. Ltd. boosted its stake in Danaher by 11.2% during the 2nd quarter. Resona Asset Management Co. Ltd. now owns 490,693 shares of the conglomerate’s stock worth $97,081,000 after acquiring an additional 49,238 shares during the last quarter. Atlantic Union Bankshares Corp boosted its stake in Danaher by 795.1% during the 2nd quarter. Atlantic Union Bankshares Corp now owns 71,724 shares of the conglomerate’s stock worth $14,168,000 after acquiring an additional 63,711 shares during the last quarter. Highlander Partners L.P. bought a new position in Danaher during the 2nd quarter worth approximately $11,062,000. Convergence Financial LLC boosted its stake in Danaher by 161.9% during the 2nd quarter. Convergence Financial LLC now owns 3,255 shares of the conglomerate’s stock worth $643,000 after acquiring an additional 2,012 shares during the last quarter. Finally, TKG Advisors LLC boosted its stake in Danaher by 4.7% during the 2nd quarter. TKG Advisors LLC now owns 9,085 shares of the conglomerate’s stock worth $1,795,000 after acquiring an additional 409 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of DHR opened at $212.34 on Thursday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $258.23. The firm’s 50 day moving average price is $203.83 and its two-hundred day moving average price is $200.07. The firm has a market cap of $149.99 billion, a P/E ratio of 43.78, a PEG ratio of 3.28 and a beta of 0.81.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The company had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $6 billion. During the same period last year, the company earned $1.71 earnings per share. The firm’s revenue was up 4.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 31st. Stockholders of record on Friday, September 26th were issued a $0.32 dividend. The ex-dividend date was Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is 26.39%.

Insider Activity

In other news, Director Teri List sold 2,778 shares of Danaher stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 11.10% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several research firms recently weighed in on DHR. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Danaher from $235.00 to $250.00 and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. UBS Group reduced their price objective on shares of Danaher from $240.00 to $225.00 and set a “buy” rating on the stock in a research note on Wednesday, July 23rd. Redburn Partners set a $220.00 price objective on shares of Danaher in a research note on Wednesday, October 8th. Guggenheim reissued a “buy” rating and set a $250.00 price objective on shares of Danaher in a research note on Wednesday, July 23rd. Finally, TD Cowen lifted their price target on shares of Danaher from $250.00 to $260.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Eighteen research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $243.39.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.